News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Melinta Therapeutics Announces IDWeek 2024 Presentations Focused on Melinta’s Portfolio of Commercial and Investigational Stage Products
Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today, ten scientific presentations with data focused on Melinta’s portfolio of commercial and investigational stage products to be shared at Infectious Disease Week (IDWeek) 2024, Oct. 16-19, 2024, in Los Angeles, Californi
Melinta Therapeutics Announces FDA Approval of KIMYRSA™ (oritavancin)
The efficacy and safety of KIMYRSA were established in the SOLO clinical trials with another oritavancin product, ORBACTIV®...
Melinta Therapeutics Announces Appointment of John Harlow as Chief Commercial Officer
Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company focused on the development and commercialization of novel...
Melinta Therapeutics Announces Appointment of Kristen Allgor as Chief Human Resources Officer
Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company focused on the development and commercialization of novel...